Anti-Mouse CD200 (Clone OX-90) - Purified in vivo PLATINUM™ Functional Grade

Contact us
Leinco Technologies
Product Code: LEI-C858
Product Group: Primary Antibodies
CodeSizePrice
LEI-C858-1.0mg1.0 mg£283.00
Quantity:
LEI-C858-5.0mg5.0 mg£456.00
Quantity:
LEI-C858-25mg25 mg£1,335.00
Quantity:
LEI-C858-50mg50 mg£1,938.00
Quantity:
LEI-C858-100mg100 mg£2,741.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rat
Antibody Isotype: IgG2a
Antibody Clonality: Monoclonal
Antibody Clone: OX-90
Regulatory Status: RUO
Target Species: Mouse
Applications:
  • Flow Cytometry
  • Immunohistochemistry (IHC)
  • In Vivo Assay
Shipping:
2-8°C
Storage:
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Further Information

Antigen Distribution:
Thymocytes, neurons, B cells, splenic follicular dendritic cells and endothelium, and subsets of T cells and dendritic cells
Concentration:
? 5.0 mg/ml
Conjugate/Tag/Label:
Purified in vivo Functional Grade, in vivo PLATINUM™
Format:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Long Description:
CD200 (OX-2) is an immune suppressor that regulates the of induction of cytokine production by conventional allostimulatory DC1,2. CD200 limits pro-inflammatory signals and has been shown to play an important role in cancer and immune disorders3,4.
Purity:
?98% monomer by analytical SEC, >95% by SDS Page
Target:
CD200

References

1. Gorczynski L, Chen Z, Hu J, et. al. J Immunol. Jan 15;162(2):774-81. 1999. 2. Koning N, Swaab DF, Hoek RM, Huitinga I. J Neuropathol Exp Neurol. Feb;68(2):159-67. 2009. 3. Stanley H. Appel, David R. Beers, Weihua Zhao. Neurobiology of Brain Disorders. 4. Liu JQ, Hu A, Zhu J, et. al. Adv Exp Med Biol. 1223:155-165. 2020.